In February, Lusine Abrahamyan, an assistant professor at the University of Toronto, was contacted by ResearchGate. Her name was listed on a 2016 paper in a heart journal, the site told her — was Abrahamyan indeed a co-author?
Um, no, she was not. In fact, before that moment, she didn’t know such a paper existed.
It turns out, Abrahamyan had supervised the thesis of the first author — who, she soon learned, had also published an identical paper in another heart journal. Both have since been retracted.
A researcher has retracted two papers after her former supervisor complained she had used his ideas and methodology.
In addition, some of the work was apparently covered by a copyright agreement.
Both papers were co-authored by the same three people. The idea theft came to light after one of the co-authors received a complaint from her former supervisor, prompting her to contact the publisher to resolve the issue.
Another editor has resigned from an earth science journal following allegations over citation irregularities, which also took down its editor-in-chief.
Pereira — based at Mykolas Romeris University in Lithuania — has co-authored multiple papers with Artemi Cerdà of the University of Valencia in Spain, who stepped down as editor-in-chief of the journal earlier this year.
All too often, when an article is flagged by a journal that’s concerned about the findings, the notice lingers in limbo, leaving readers unclear whether or not to rely on the findings. One chemistry paper’s two-year stint in purgatory ended last month, when the journal lifted its expression of concern (EOC) and replaced it with a correction.
The journal chose to swap the 2015 EOC with a correction after the authors addressed its concerns in a follow-up paper, also published in Organic & Biomolecular Chemistry.
The journal’s executive editor Richard Kelly provided further insights about what happened:
An internal review by Cornell University has concluded that a high-profile researcher whose work has been under fire made numerous mistakes in his work, but did not commit misconduct.
Starting to get bored of stings designed to expose the well-documented flaws in scientific publishing? Yeah, sometimes we are too. But another one just came across our desks, and we couldn’t help ourselves.
John McCool is neither a researcher nor a urologist. When received an unsolicited invitation to submit a paper to an open-access urology journal, however, he just couldn’t resist: He is the owner of a freelance scientific editing company, and has long been concerned about so-called predatory journals, which often publish sub-par papers as long as authors pay. And he loves the TV show “Seinfeld.”
Like many others before him, McCool decided to punk the journal by submitting a fake paper. He told us:
U.S. Supreme Court nominee Neil Gorsuch appears to have borrowed material from multiple authors in his 2006 book, according to a new analysis by Politico.
This week, U.S. lawmakers are going head-to-head over the nomination of Gorsuch to the highest court in the land. Although the book is only one snippet of Gorsuch’s vast portfolio of writings, six independent experts contacted by Politico agreed that the flagged passages appear problematic.
Here’s more about documents obtained by the media outlet:
A high-profile pediatric oncologist quietly left his former institution in 2015 after it concluded his clinical trials had been affected by significant “administrative problems.” But now the results of the university’s investigations and what followed have become public, after a paper in Belgium published a series of news reports last month.
We’re still hazy on some details of the case. The recent news reports allege that Van Gool started some clinical trials without proper ethical approvals and informed consent, and may have misled patients and their families about the benefits and potential side effects of his experimental treatment. Meanwhile, the CEO University Hospitals Leuven (UZLeuven) told us that Stefaan Van Gool, who had appointments at both the hospital and the university (KULeuven), left the hospital in 2015 as a result of administrative problems, but did not disclose the specific nature of these issues.
For the past 15 years or so, Van Gool has been developing and studying a vaccine to treat various cancers, initially at UZLeuven and, after September 2015, at a private clinic in Germany. Today, patients travel to his private clinic from all over the world and pay tens of thousands of dollars to receive the vaccine. But according to Flemish daily newspaper De Standaard, several years ago, UZLeuven began investigating his research and patient care practices. The outcome of these investigations was kept private until last month, after De Standaard published its reports.
Marc Decramer, the CEO of UZLeuven, confirmed that Van Gool left the hospital in 2015 and the university in 2016,but did not provide the specific reasons for his exit:
We’ve known for a while that too many researchers cite retracted papers. But in what context do those citations occur? Are some authors citing a retracted paper as an example of problematic findings, or do most citing authors treat the findings as legitimate, failing to realize they are no longer valid? In a new paper in Scientometrics, Gali Halevi at Icahn School of Medicine at Mount Sinai in New York and Judit Bar-Ilan at Bar-Ilan University in Israel examined citations to 15 papers retracted in 2014. Halevi told us why she was surprised to see how many authors don’t realize retracted papers are problematic, and what the publishing community can do to get the word out.
Retraction Watch: We’ve noticed that many papers are cited long after being retracted, without notifying readers the paper is problematic. You looked at citations to retracted papers and tracked how the citing authors described the paper – noting that its findings were problematic given the retraction (negative), or treating the findings as legitimate research that affirms the newer paper’s results (positive). The vast majority of post-retraction citations – 83% — were positive. Did that surprise you?
According to an internal email to staff forwarded to us last year, the university concluded that Robert Ryan had misrepresented clinical data and images in 12 different publications. The first retraction, published by Molecular Microbiology, cites image duplications in multiple figures.